Raymond James Financial
RMD icon

Raymond James Financial’s ResMed RMD Stock Holding History

Raymond James Financial’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.93M Sell
50,933
-8,263
-14% -$1.71M ﹤0.01% 2166
2026
Q1 		$13.3M Buy
59,196
+1,717
+3% +$428K ﹤0.01% 1782
2025
Q4 		$13.8M Buy
57,479
+3,670
+7% +$939K ﹤0.01% 1712
2025
Q3 		$14.7M Buy
53,809
+5,697
+12% +$1.56M ﹤0.01% 1632
2025
Q2 		$12.4M Buy
48,112
+5,242
+12% +$1.25M ﹤0.01% 1714
2025
Q1 		$9.6M Buy
42,870
+1,075
+3% +$251K ﹤0.01% 1839
2024
Q4 		$9.56M Buy
+41,795
New +$10.1M ﹤0.01% 1885

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Raymond James Financial's RMD Position: Q2 2026 in Review

Raymond James Financial reduced its ResMed (RMD) stake by 14% in Q2 2026, selling an estimated $1.71M and leaving 50,933 shares worth $9.93M. The position accounts for ﹤0.01% of the portfolio, ranked #2166.

Raymond James Financial first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $14.7M in Q3 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Raymond James Financial held 50,933 shares of ResMed worth $9.93M as of Q2 2026.
  • Raymond James Financial sold 8,263 ResMed shares in Q2 2026, an estimated $1.71M.
  • ResMed made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2166 holding.
  • Raymond James Financial first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's ResMed position peaked at $14.7M in Q3 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.